Back

Aligos Therapeutics Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

Buy

ALGS
Aligos Therapeutics

Last Price:

$43.62

Seasonality Move:

7.18%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Aligos Therapeutics Stock Forecast

Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 11.8% based on the past 4 years of stock performance.
Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Is Aligos Therapeutics Stock Undervalued?

The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Aligos Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Aligos Therapeutics has on average historically fallen by 11.8% based on the past 4 years of stock performance.

Aligos Therapeutics Stock Rating

Buy

Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics overpriced?

Aligos Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Aligos Therapeutics Stock Price History

Is ALGS stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

aligos.com

52-Week Data

52-Week High:

43.94

52-Week Low:

6.76

Prediction Charts

Market Cap:

155.6M

Price in USD:

43.37

Volume:

784.9K

Beta:

2.75

Technical Analysis

SMA50:

20.60

SMA100:

16.03

SMA200:

16.51

52-Wk Change:

135.07%

Stock Predictions

Is Aligos Therapeutics stock public?

Yes, Aligos Therapeutics is a publicly traded company.
What is the Aligos Therapeutics stock quote today?

The Aligos Therapeutics stock price is 43.37 USD today.
How to buy Aligos Therapeutics stock online?

You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-6	28.82	28.67	30.43	27.41
Dec-9	28.67	27.56	28.67	25.52
Dec-10	28.52	30.82	31.80	27.10
Dec-11	32.00	34.53	34.70	30.41
Dec-12	34.26	33.11	35.30	32.20
Dec-13	35.33	34.07	35.45	32.00
Dec-16	34.08	33.66	35.89	33.01
Dec-17	33.93	34.47	34.99	28.00
Dec-18	35.51	33.02	38.30	31.11
Dec-19	35.00	38.35	39.30	34.60
Dec-20	36.78	39.78	41.64	36.35
Dec-23	42.10	38.85	42.95	38.61
Dec-24	40.98	39.34	42.42	38.90
Dec-26	40.00	43.37	43.94	38.13

Aligos Therapeutics Earnings

Aligos Therapeutics Earnings Report: Per Share Aligos Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aligos Therapeutics Forecast Revenue Growth

Aligos Therapeutics Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.